The Food and Drug Administration on Tuesday approved the first drug to treat Friedreich’s ataxia, a rare, neurological disease.
The new drug, called Skyclarys, is made by Reata Pharmaceuticals.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
